Literature DB >> 22571079

Myxoma developing after open heart surgery: is radiofrequency ablation responsible for the formation of the tumor?

G Sirin1, E Ozker, H Fotbolcu, K Ozden, E Demirsoy.   

Abstract

34-year-old male with history of recurrent atrial fibrillation (AF) and mitral stenosis, status post radiofrequency ablation (RFA) and prosthetic mitral valve replacement two years earlier was admitted with prosthetic valve thrombosis for redo mitral valve surgery. During the surgery, a 2 x 1.5 x 1 cm mass was identified on the interatrial septum, attached to the edge of tricuspid valve's septal leaflet by a stalk. The mass was excised and histological evaluation revealed myxoma. It is accepted that myxomas can develop after cardiac trauma. It is known that RFA for AF increases the risk of thrombus or endocarditis in the atrium. Herein, we report a myxoma case where we think the heat energy caused by RFA might have triggered the development of the tumor.

Entities:  

Mesh:

Year:  2012        PMID: 22571079     DOI: 10.1080/00015458.2012.11680814

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  3 in total

1.  Left atrial myxoma development after radiofrequency ablation of an atrial flutter substrate.

Authors:  Elpidio Santillo; Monica Migale; Luciano Marini; Luca Fallavollita; Carlo Massini; Fabrizio Balestrini
Journal:  J Cardiol Cases       Date:  2015-02-20

2.  Usefulness of CHA2DS2-VASc Scoring Systems for Predicting Risk of Perioperative Embolism in Patients of Cardiac Myxomas Underwent Surgical Treatment.

Authors:  Liang Yin; Jing Wang; Wei Li; Xinyu Ling; Qian Xue; Yufeng Zhang; Zhinong Wang
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

3.  Growth rate of an apical left ventricular myxoma using serial two dimensional echocardiographic and computed tomography observations over twelve months: a case report.

Authors:  Panagiota Kourkoveli; Dimitrios Tsiapras; Evaggelia Grisbolaki; Olga Karapanagiotou; Stamatina Kampanarou; Stamatis Kyrzopoulos; Loukas Kaklamanis; Mazen Khoury; Vassilis Voudris
Journal:  J Med Case Rep       Date:  2014-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.